Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.
基線特徵對於參與者使用每週一次皮下注射 semaglutide 治療 2 型糖尿病的療效影響:SUSTAIN China 的事後分析。
Diabetes Obes Metab 2024-09-16
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).
第二型糖尿病患者皮下注射 semaglutide 的實際效果:一項回顧性的世界真實研究(Sema-MiDiab01)。
Front Endocrinol (Lausanne) 2023-02-08
Real-world impact of once-weekly subcutaneous semaglutide after 2 years of follow-up: Results from a nationwide observational study in people with type 2 diabetes.
經過2年追蹤後,一周一次皮下注射semaglutide對2型糖尿病患者的真實世界影響:來自全國性觀察性研究的結果。
Diabetes Obes Metab 2023-05-13
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.
BMI和合併症對一周一次的semaglutide療效的影響:STEP 1隨機試驗的事後分析。
Obesity (Silver Spring) 2023-10-14
Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings.
口服 Semaglutide 在日本臨床環境中對二型糖尿病的有效性的回顧性分析,以及其對心血管代謝參數的影響。
J Cardiovasc Dev Dis 2023-05-01
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China.
使用一周一次的semaglutide治療,與對照組相比,達到代謝綜合終點的2型糖尿病參與者比例:來自SUSTAIN 1-5、7-10和SUSTAIN China的事後合併分析。
Diabetes Obes Metab 2023-12-16
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes.
一周一次的Semaglutide與每日一次的Sitagliptin作為二甲双胍附加治療,對韓國2型糖尿病患者的療效和安全性。
Diabetes Ther 2024-02-07
The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China.
一周一次的semaglutide與sitagliptin在中國治療2型糖尿病的長期成本效益。
Health Econ Rev 2024-04-05
Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients - Real World Study.
Semaglutide對糖尿病患者代謝結果的影響-真實世界研究。
Diabetes Metab Syndr Obes 2024-04-25
Real-world HbA<sub>1c</sub> changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.
開始使用一周一次的semaglutide治療糖尿病的2型糖尿病患者的實際HbA<sub>1c</sub>變化和處方特徵。
J Diabetes Metab Disord 2024-06-27
Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).
西班牙 2 型糖尿病患者每週一次皮下注射 Semaglutide 的實際評估(SEMA-RW 研究)。
Nutrients 2024-08-10